16 April 2021
Case Study: Inside Geneva’s Sprint to Support COVID-19 Vaccines
When the federal government unveiled Operation Warp Speed (OWS) in May 2020, it was “unlike anything our country has seen since the Manhattan Project.” The multi-agency initiative’s central goal – to develop, produce, and distribute 300 million doses of a safe and effective coronavirus vaccine by January 2021 – requires a deep knowledge of science and how to manage complex government operations while navigating a challenging pandemic.
OWS was premised on setting an ambitious goal – one that initially seemed impossible but became increasingly achievable. “We had three weeks to have equipment and materials set up and ready to go,” said Geneva Program Manager Sara Bergeron. “OWS quickly became a 24/7 job for our team.”
In this Case Study, you will find:
- Benefits of working with military populations in clinical trials
- Map of military treatment facilities Geneva is working with to advance Operation Warp Speed
- Timeline of clinical trials
- Regulatory expertise
- Types of positions needed to support OWS
Download Now
